Jeff Abel

Title: Jeff Abel: Innovator in Pharmaceutical Composition

Introduction

Jeff Abel is a notable inventor based in Simi Valley, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bispecific antibody constructs. His innovative work aims to improve the storage and administration of pharmaceutical compositions.

Latest Patents

Jeff Abel holds a patent for a pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration. The invention provides an enhanced pharmaceutical composition that includes a bispecific antibody construct, a preservative, and a diluent. This composition ensures that the bispecific antibody construct remains stable and recoverable, with concentrations ranging from about 0.5 μg/ml to 20 mg/ml.

Career Highlights

Throughout his career, Jeff has worked with prominent companies in the biotechnology sector. He has been associated with Amgen Inc. and Amgen Research GmbH, where he has contributed to various innovative projects. His expertise in pharmaceutical development has made him a valuable asset in these organizations.

Collaborations

Jeff has collaborated with talented individuals in his field, including Lingwen Cui and Devrishi Goswami. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical technologies.

Conclusion

In summary, Jeff Abel is a distinguished inventor whose work in pharmaceutical compositions has the potential to enhance the efficacy and safety of medical treatments. His contributions to the field are noteworthy and reflect his commitment to innovation in healthcare.